Literature DB >> 36261523

Clathrin-associated AP-1 controls termination of STING signalling.

Ying Liu1, Pengbiao Xu1, Sophie Rivara1, Chong Liu1, Jonathan Ricci1, Xuefeng Ren2, James H Hurley2,3, Andrea Ablasser4.   

Abstract

Stimulator of interferon genes (STING) functions downstream of cyclic GMP-AMP synthase in DNA sensing or as a direct receptor for bacterial cyclic dinucleotides and small molecules to activate immunity during infection, cancer and immunotherapy1-10. Precise regulation of STING is essential to ensure balanced immune responses and prevent detrimental autoinflammation11-16. After activation, STING, a transmembrane protein, traffics from the endoplasmic reticulum to the Golgi, where its phosphorylation by the protein kinase TBK1 enables signal transduction17-20. The mechanism that ends STING signalling at the Golgi remains unknown. Here we show that adaptor protein complex 1 (AP-1) controls the termination of STING-dependent immune activation. We find that AP-1 sorts phosphorylated STING into clathrin-coated transport vesicles for delivery to the endolysosomal system, where STING is degraded21. We identify a highly conserved dileucine motif in the cytosolic C-terminal tail (CTT) of STING that, together with TBK1-dependent CTT phosphorylation, dictates the AP-1 engagement of STING. A cryo-electron microscopy structure of AP-1 in complex with phosphorylated STING explains the enhanced recognition of TBK1-activated STING. We show that suppression of AP-1 exacerbates STING-induced immune responses. Our results reveal a structural mechanism of negative regulation of STING and establish that the initiation of signalling is inextricably associated with its termination to enable transient activation of immunity.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36261523     DOI: 10.1038/s41586-022-05354-0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


  51 in total

1.  Design of amidobenzimidazole STING receptor agonists with systemic activity.

Authors:  Joshi M Ramanjulu; G Scott Pesiridis; Jingsong Yang; Nestor Concha; Robert Singhaus; Shu-Yun Zhang; Jean-Luc Tran; Patrick Moore; Stephanie Lehmann; H Christian Eberl; Marcel Muelbaier; Jessica L Schneck; Jim Clemens; Michael Adam; John Mehlmann; Joseph Romano; Angel Morales; James Kang; Lara Leister; Todd L Graybill; Adam K Charnley; Guosen Ye; Neysa Nevins; Kamelia Behnia; Amaya I Wolf; Viera Kasparcova; Kelvin Nurse; Liping Wang; Ana C Puhl; Yue Li; Michael Klein; Christopher B Hopson; Jeffrey Guss; Marcus Bantscheff; Giovanna Bergamini; Michael A Reilly; Yiqian Lian; Kevin J Duffy; Jerry Adams; Kevin P Foley; Peter J Gough; Robert W Marquis; James Smothers; Axel Hoos; John Bertin
Journal:  Nature       Date:  2018-11-07       Impact factor: 49.962

2.  Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic.

Authors:  Chenguang Yu; Vincent F Vartabedian; Ying Jia; H Michael Petrassi; Emily N Chin; Manoj Kumar; Ana M Gamo; William Vernier; Sabrina H Ali; Mildred Kissai; Daniel C Lazar; Nhan Nguyen; Laura E Pereira; Brent Benish; Ashley K Woods; Sean B Joseph; Alan Chu; Kristen A Johnson; Philipp N Sander; Francisco Martínez-Peña; Eric N Hampton; Travis S Young; Dennis W Wolan; Arnab K Chatterjee; Peter G Schultz; John R Teijaro; Luke L Lairson
Journal:  Science       Date:  2020-08-21       Impact factor: 47.728

3.  An orally available non-nucleotide STING agonist with antitumor activity.

Authors:  Bo-Sheng Pan; Samanthi A Perera; Jennifer A Piesvaux; Jeremy P Presland; Gottfried K Schroeder; Jared N Cumming; B Wesley Trotter; Michael D Altman; Alexei V Buevich; Brandon Cash; Saso Cemerski; Wonsuk Chang; Yiping Chen; Peter J Dandliker; Guo Feng; Andrew Haidle; Timothy Henderson; James Jewell; Ilona Kariv; Ian Knemeyer; Johnny Kopinja; Brian M Lacey; Jason Laskey; Charles A Lesburg; Rui Liang; Brian J Long; Min Lu; Yanhong Ma; Ellen C Minnihan; Greg O'Donnell; Ryan Otte; Laura Price; Larissa Rakhilina; Berengere Sauvagnat; Sharad Sharma; Sriram Tyagarajan; Hyun Woo; Daniel F Wyss; Serena Xu; David Jonathan Bennett; George H Addona
Journal:  Science       Date:  2020-08-21       Impact factor: 47.728

4.  Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.

Authors:  Leticia Corrales; Laura Hix Glickman; Sarah M McWhirter; David B Kanne; Kelsey E Sivick; George E Katibah; Seng-Ryong Woo; Edward Lemmens; Tamara Banda; Justin J Leong; Ken Metchette; Thomas W Dubensky; Thomas F Gajewski
Journal:  Cell Rep       Date:  2015-05-07       Impact factor: 9.423

5.  Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA.

Authors:  Jiaxi Wu; Lijun Sun; Xiang Chen; Fenghe Du; Heping Shi; Chuo Chen; Zhijian J Chen
Journal:  Science       Date:  2012-12-20       Impact factor: 47.728

6.  The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING.

Authors:  Elie J Diner; Dara L Burdette; Stephen C Wilson; Kathryn M Monroe; Colleen A Kellenberger; Mamoru Hyodo; Yoshihiro Hayakawa; Ming C Hammond; Russell E Vance
Journal:  Cell Rep       Date:  2013-05-23       Impact factor: 9.423

7.  Cyclic [G(2',5')pA(3',5')p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase.

Authors:  Pu Gao; Manuel Ascano; Yang Wu; Winfried Barchet; Barbara L Gaffney; Thomas Zillinger; Artem A Serganov; Yizhou Liu; Roger A Jones; Gunther Hartmann; Thomas Tuschl; Dinshaw J Patel
Journal:  Cell       Date:  2013-05-03       Impact factor: 41.582

8.  STING is a direct innate immune sensor of cyclic di-GMP.

Authors:  Dara L Burdette; Kathryn M Monroe; Katia Sotelo-Troha; Jeff S Iwig; Barbara Eckert; Mamoru Hyodo; Yoshihiro Hayakawa; Russell E Vance
Journal:  Nature       Date:  2011-09-25       Impact factor: 49.962

9.  STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling.

Authors:  Hiroki Ishikawa; Glen N Barber
Journal:  Nature       Date:  2008-08-24       Impact factor: 49.962

10.  cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING.

Authors:  Andrea Ablasser; Marion Goldeck; Taner Cavlar; Tobias Deimling; Gregor Witte; Ingo Röhl; Karl-Peter Hopfner; Janos Ludwig; Veit Hornung
Journal:  Nature       Date:  2013-05-30       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.